Navigation Links
Tumor Painting to Fight Against Cancer

A tumor paint developed by researchers at Seattle Childrens Hospital Research Institute and Fred Hutchinson Cancer Research Center will help surgeons see where a tumor begins and ends more precisely by illuminating the cancerous cells.

The paint is a scorpion-derived peptide called chlorotoxin that is linked to the molecular beacon Cy5.5.Until now there has been no way to allow surgeons to see tumors live during surgery.

Chlorotoxin:Cy5.5 is a fluorescent molecular beacon that emits photons in the near infrared spectrum. This illumination gives surgeons a better chance of removing all of the cancerous cells during surgery without injuring surrounding healthy tissue.

This is particularly significant in the brain, where approximately 80% of malignant cancers recur at the edges of the surgical site. Current technology, such as magnetic resonance imaging (MRI) can distinguish tumors from healthy tissue only if more than 1 million cancer cells are present.

But Cy5.5 can identify tumors with as few as 2000 cancer cells, making it 500 times more sensitive than MRI.

"My greatest hope is that tumor paint will fundamentally improve cancer therapy, said James M. Olson, MD, PhD, of Seattle Childrens Hospital and The Hutchison Center who is the senior author of the study. By allowing surgeons to see cancer that would be undetectable by other means, we can give our patients better outcomes.

Olson led the team that included neurosurgeons, engineers and biologists. The bioconjugate, Chlorotoxin:Cy5.5 which, when injected, emits a near-infrared light, was created in his laboratory at the Hutchinson Center.

In mouse models, the team demonstrated that they could light up brain tumors as small as 1 millimeter in diameter without lighting up the surrounding normal brain tissue. In a prostate cancer model, as few as 200 cancer cells traveling in a mouse lymph channel could be detected.


'"/>




Page: 1 2 3

Related medicine news :

1. Use of Cellular Phones associated with Increased risk of Brain Tumors
2. Radiofrequency Energy Cooks Tumors Without Surgery
3. New Liver Tumor Treatment
4. Latest Tumor Classification More Informative
5. New Technique For Benign Breast Tumors
6. Another Treatment Option for Benign Tumors
7. Understanding The Origin Of Tumors
8. Outpatient Treatment Possible For Patients with Uterine Fibroid Tumors
9. Stem Cells, Tumor Cells Share Similar Properties: Scope For Treatment and Prevention?
10. Lipoma Arborescens: A Rare Tumor Of The Knee
11. Researchers Develop Mouse Model Of Brain Tumor
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Tumor Painting Fight Against Cancer

(Date:7/28/2015)... ... July 28, 2015 , ... opaJUMP! ... to measure and produce health outcomes associated with its training methods. This company ... a small group pre-post study, conducted in early 2015, training yielded an average ...
(Date:7/28/2015)... (PRWEB) , ... July 28, 2015 , ... Healthpointe ... injectable that returns skin to a smooth state, and reduces the appearance of fine ... “first and only FDA-approved injectable gel to instantly add volume to your cheek area ...
(Date:7/28/2015)... Angeles, CA (PRWEB) , ... July 28, 2015 , ... ... highs several times a day to a few times a year. The World Health ... research study by the National Institute of Mental Health reveals that the United States ...
(Date:7/28/2015)... Raleigh, NC (PRWEB) , ... July 28, 2015 ... ... others cancers are more common in shipbreaking workers than they are in the ... Click here to read it now. , Researchers at Taiwan’s National ...
(Date:7/28/2015)... ... July 28, 2015 , ... A new study published by HealthDay News ... " sheds light on a possible new treatment option for people living with fibromyalgia ... HBOT sessions, at least five per week, patients experienced a significant decrease in pain, ...
Breaking Medicine News(10 mins):Health News:opaJUMP Launches First Case Study in Thyroid Health: How Rebounding Helped One Woman Stabilize Her Thyroid in Seven Weeks 2Health News:opaJUMP Launches First Case Study in Thyroid Health: How Rebounding Helped One Woman Stabilize Her Thyroid in Seven Weeks 3Health News:opaJUMP Launches First Case Study in Thyroid Health: How Rebounding Helped One Woman Stabilize Her Thyroid in Seven Weeks 4Health News:opaJUMP Launches First Case Study in Thyroid Health: How Rebounding Helped One Woman Stabilize Her Thyroid in Seven Weeks 5Health News:opaJUMP Launches First Case Study in Thyroid Health: How Rebounding Helped One Woman Stabilize Her Thyroid in Seven Weeks 6Health News:opaJUMP Launches First Case Study in Thyroid Health: How Rebounding Helped One Woman Stabilize Her Thyroid in Seven Weeks 7Health News:Healthpointe’s Cosmetic Laser Institute Now Providing Juvéderm Voluma XC in Anaheim 2Health News:Healthpointe’s Cosmetic Laser Institute Now Providing Juvéderm Voluma XC in Anaheim 3Health News:"I Am Not I" Music Video Raises Bipolar Disorder Awareness 2Health News:New Findings Suggest Mesothelioma is Not the Only Cancer Threat for Shipbreakers, According to Surviving Mesothelioma 2Health News:Recovery Specialists Discuss How Oxygen Therapy Can Ease Fibromyalgia 2Health News:Recovery Specialists Discuss How Oxygen Therapy Can Ease Fibromyalgia 3
... Clinical Imaging, Inc., in collaboration with investigators at The ... $1.6 million, three-year grant from the National Institutes of ... imaging software that aids the diagnosis and treatment of ... will allow us to refine and validate new methods ...
... Fla. - Results of a Mayo Clinic study ... to a coronary angioplasty ( http://www.mayoclinic.org/heart-catheterization/types.html ) remained ... is good news because physicians now are performing ... sicker and need more complicated treatment. The ...
... International Chronic Total Occlusion (CTO) Summit is a ... new developments in therapeutic procedures essential for interventional ... occlusions. This year,s summit will include: ... review sessions, Thematically organized live coronary CTO cases ...
... 16 GetWellNetwork, Inc. today announced ... Perry, an experienced high-tech leader and market strategist, will help ... deliver on the promise of improving patient care through its ... Perry will focus on GetWellNetwork,s leadership position in shaping the ...
... flibanserin, expert says, , MONDAY, Nov. 16 (HealthDay News) -- ... been touted as a female version of Viagra, can enhance ... compiles the results of several trials, the first to test ... the brain, lead investigator Dr. John M. Thorp Jr., a ...
... was originally created as an antidepressant, is effective in treating ... trials have found. These trials were the first ever ... the brain to enhance libido in women reporting low sexual ... of obstetrics and gynecology at the University of North Carolina ...
Cached Medicine News:Health News:Prism and Medical College of Wisconsin investigators receive $1.6 million NIH grant to develop advanced medical imaging tools 2Health News:Prism and Medical College of Wisconsin investigators receive $1.6 million NIH grant to develop advanced medical imaging tools 3Health News:Mayo study shows stroke incidence related to angioplasty remains steady over past 15 years 2Health News:GetWellNetwork Taps High-Tech Veteran Michele Perry as Chief Operating Officer 2Health News:Study Touts Success With 'Female Viagra' Drug 2Health News:Viagra for women? Drug developed as antidepressant effective in treating low libido 2
(Date:7/28/2015)... , July 28, 2015 ... research report with market overview, trends, DRO ... porter analysis, recent developments, competitive scenario and ... Industry Insight: Human Insulin Market Development and ... (Logo: http://photos.prnewswire.com/prnh/20150727/756778) Explore more about ...
(Date:7/28/2015)... and LINCOLNSHIRE, Ill. , ... clinical laboratories to leverage business acumen on par with ... American Association of Clinical Chemistry (AACC) Annual Meeting & ... Beyond a Better Box™ to deliver a comprehensive and ... future unfolds. With advances in four key areas, Sysmex ...
(Date:7/28/2015)... SOUTH SAN FRANCISCO, Calif. , July 28, ... ) today announced that it will report its ... Tuesday, August 4, 2015.  Rigel senior management will ... and webcast at 4:30pm Eastern Time (1:30pm Pacific ... Participants can access the live conference call by ...
Breaking Medicine Technology:Global Human Insulin Market (Size of $24 billion in 2014) to Witness 13% CAGR During 2015 - 2020 2Global Human Insulin Market (Size of $24 billion in 2014) to Witness 13% CAGR During 2015 - 2020 3Global Human Insulin Market (Size of $24 billion in 2014) to Witness 13% CAGR During 2015 - 2020 4Global Human Insulin Market (Size of $24 billion in 2014) to Witness 13% CAGR During 2015 - 2020 5Sysmex Moves Beyond a Better Box 2Sysmex Moves Beyond a Better Box 3Sysmex Moves Beyond a Better Box 4Rigel Announces Conference Call and Webcast to Report Second Quarter 2015 Financial Results 2
... Pfizer said today that,results showing potential across numerous ... cell lung (NSCLC), colorectal,(CRC) and renal cell carcinoma ... will be presented next week at the American ... "Each person with cancer responds differently to treatment, ...
... /PRNewswire/ -- Phase II,results exceed expectations - Alchemia ... development company Alchemia Limited will,commence discussions with the ... conclusion of the Phase II clinical trial,of its ... data from the randomized Phase II clinical trial ...
Cached Medicine Technology:New Pfizer Oncology Data Across Numerous Cancer Types to be,Presented at ASCO 2New Pfizer Oncology Data Across Numerous Cancer Types to be,Presented at ASCO 3New Pfizer Oncology Data Across Numerous Cancer Types to be,Presented at ASCO 4New Pfizer Oncology Data Across Numerous Cancer Types to be,Presented at ASCO 5Positive Final Data from HyCAMP Phase II Trial in Metastatic,Colorectal 2Positive Final Data from HyCAMP Phase II Trial in Metastatic,Colorectal 3Positive Final Data from HyCAMP Phase II Trial in Metastatic,Colorectal 4
The GENESIS II* Total Knee System will define the state of knee implants....
... system's curved-on-curved articulation maintains full inter-changeability. ... options for better patient fit. The ... spray porous coating, which offers an ... processed polyethylene is used for consistent, ...
... new generation of posterior stabilized knee ... the following: Patellar flange mates with ... machined condyles assure precise, repeatable kinematics ... and patella to reduce wear. Constant ...
... The TC-PLUS solution tricompartmental total knee prosthesis ... knee arthroplasty. State-of-the-art design and manufacturing technologies ... optimum biomechanical function as well as a ... tibial insert to keep wear to a ...
Medicine Products: